Notable Two Hundred Day Moving Average Cross - BRLI Friday, February 1, 11:39 AM ET, by Market News Video Staff In trading on Friday, shares of Bio-Reference Laboratories, Inc. (BRLI) crossed below their 200 day ...
HMSY Crosses Above Key Moving Average Level Wednesday, February 27, 11:28 AM ET, by Market News Video Staff In trading on Wednesday, shares of HMS Holdings Corp (HMSY) crossed above their 200 day ...
Bargain Hunters Take Note: Insider Cluster-Buying At AMED
By Market News Video Staff, Tuesday, November 22, 12:11 PM ET
A particularly strong insider buying signal is what we call a "cluster-buy" where three or more different insiders make open market purchases within a short period of one another. At Amedisys, Inc. (NASDAQ:AMED), 3 different insiders purchased 8,483 shares at an average price of $10.49/share, for a total of $88,993, with the most recent purchase on November 14, 2011.
Presumably the only reason an insider would take their hard-earned cash and use it to buy stock of their company in the open market, is that they expect to make money. So when multiple insiders all decide to make purchases around the same time, it could be a strong indication that the stock is undervalued. Below is a table summarizing the insider buys that make up this "cluster":
Purchased
Insider
Title
Shares
Price/Share
Value
11/04/2011
Peter Ricchiuti
Director
1,633
$9.66
$15,773.15
11/07/2011
David R Pitts
Director
4,850
$10.25
$49,719.40
11/14/2011
Jack L Netterville
Director
2,000
$11.75
$23,500.00
The chart below shows the one year performance of AMED shares, versus its 200 day moving average. Note that AMED's low point in its 52 week range is $9.12 per share, with $38.87 as the 52 week high point — that compares with a last trade of $10.56, with shares currently trading off about 4.7% on the day.
According to the ETF Finder at ETF Channel, AMED makes up 1.30% of the SPDR S&P Health Care Services ETF (AMEX:XHS) which is trading relatively unchanged on the day Tuesday.
AMED operates in the Diagnostics sector, among companies like Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) which is down about 1.5% today, and Landauer, Inc. (NYSE:LDR) trading lower by about 0.6%. Below is a three month price history chart comparing the stock performance of AMED, versus BRLI and LDR.
The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors —
anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset
allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors,
commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow
the performance trail wherever it leads us.
This Article's Word Cloud:AMEDBRLIBelowChannelDirectorInvestmentValueaboutallowsaroundassetaveragecashchartclustercompletelycurrentlydecidedesigneddifferentinsiderinsidersmakemarketmostopenotherperformancepointportfoliopricepurchasessharesharesshortstockstocksstrongthattheirthisthreetradingunchangedversusweekwhatwhenwhichwith
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
Daily Wrap: May 10, 2013
Analyst Moves: RIG, APC, BSX
Analyst Moves: DISH, MDR, PCLN
Daily Wrap: May 9, 2013
Daily Dividend Report: CRI, WM, CHRW, NVDA, CBI
Friday 5/10 Insider Buying Report: ROIC